GlassScriptPhysician profile
Steven K Hopf
NPI 1417953266
$411.86
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $67.01 · 2021: $135 · 2022: $70.84.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $168.52 | 2019-2022 | |
| Allergan, INC. | $59.46 | 2019 | |
| Merck Sharp & Dohme LLC | $35.79 | 2019-2021 | |
| Pfizer INC. | $26.70 | 2021 | |
| Hologic Sales and Service, LLC | $25.36 | 2019 | |
| Medtronic, INC. | $16.76 | 2022 | |
| Ethicon US, LLC | $14.27 | 2021 | |
| Sanara Medtech INC. | $14.07 | 2021 | |
| Meditrina | $13.65 | 2021 | |
| Exeltis, USA INC. | $12.79 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.33 | 2019 | |
| Amneal Pharmaceuticals LLC | $12.16 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Hopf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.